Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8263 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.82 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8072 |
Intermediate Similarity |
NPD6764 |
Approved |
0.8072 |
Intermediate Similarity |
NPD6765 |
Approved |
0.8063 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7882 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7821 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7785 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD919 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7683 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD920 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7643 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7574 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7561 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD17 |
Approved |
0.7532 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7442 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7434 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD4107 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7346 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7285 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7244 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7228 |
Intermediate Similarity |
NPD4482 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7212 |
Intermediate Similarity |
NPD37 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7192 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7186 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7186 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7176 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7095 |
Approved |
0.716 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1049 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5403 |
Approved |
0.711 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.707 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD5402 |
Approved |
0.702 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.6994 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD5735 |
Approved |
0.6987 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6978 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6663 |
Approved |
0.6968 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6966 |
Remote Similarity |
NPD2971 |
Approved |
0.6966 |
Remote Similarity |
NPD2968 |
Approved |
0.6964 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD2801 |
Approved |
0.6962 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD1283 |
Approved |
0.6946 |
Remote Similarity |
NPD6677 |
Suspended |
0.6939 |
Remote Similarity |
NPD9545 |
Approved |
0.6937 |
Remote Similarity |
NPD2897 |
Discontinued |
0.6932 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD5736 |
Approved |
0.6923 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD5353 |
Approved |
0.6918 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6915 |
Remote Similarity |
NPD3057 |
Approved |
0.6914 |
Remote Similarity |
NPD7228 |
Approved |
0.6914 |
Remote Similarity |
NPD2354 |
Approved |
0.6905 |
Remote Similarity |
NPD6280 |
Approved |
0.6905 |
Remote Similarity |
NPD6279 |
Approved |
0.6897 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD2800 |
Approved |
0.6892 |
Remote Similarity |
NPD1651 |
Approved |
0.6887 |
Remote Similarity |
NPD4359 |
Approved |
0.6875 |
Remote Similarity |
NPD7054 |
Approved |
0.6875 |
Remote Similarity |
NPD5535 |
Approved |
0.6875 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6851 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6842 |
Remote Similarity |
NPD8651 |
Approved |
0.6839 |
Remote Similarity |
NPD5242 |
Approved |
0.6836 |
Remote Similarity |
NPD7472 |
Approved |
0.6835 |
Remote Similarity |
NPD1607 |
Approved |
0.6832 |
Remote Similarity |
NPD4534 |
Discontinued |
0.6829 |
Remote Similarity |
NPD1511 |
Approved |
0.6825
|
Remote Similarity |
NPD2972 |
Approved |